CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 35,324 shares (grant or award)
- 4 Grant or award Director acquired 21,389 shares (grant or award)
- 4 Grant or award Director acquired 25,602 shares (grant or award)
- 4 Grant or award Director acquired 22,685 shares (grant or award)
- 4 Open-market buy 10% owner bought 617,731 shares at $1.40 ($864,823)
- 4 Open-market buy 10% owner bought 1,947,052 shares at $1.40 ($2,725,873)
- 4 Open-market buy 10% owner bought 974,081 shares at $1.40 ($1,363,713)
- 4 Open-market buy Director bought 6,695 shares at $1.40 ($9,373)
- 4 Open-market buy Chief Operating Officer bought 6,695 shares at $1.40 ($9,373)
- 4 Open-market buy President & CEO bought 10,042 shares at $1.40 ($14,059)
- 4 Open-market buy Sr VP Finance & CAO bought 3,347 shares at $1.40 ($4,686)
- 4 Open-market buy Director bought 6,695 shares at $1.40 ($9,373)
- 4 Open-market buy Director bought 15,000 shares at $1.40 ($21,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Grant or award Director acquired 33,182 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 14 of 28 · 551 filings